To find out whether Mifepristone (a medicine commonly used for aborting a pregnancy) has a role in effectively starting delivery pains in pregnant women with a dead baby in the womb.

Role of Mifepristone for Induction of Labour in Women with Intrauterine Fetal Death: A Randomized Double Blind Placebo-controlled Trial - MILI

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/10/058199

Enrollment

Registered

2023-10-03

Start date

Unknown

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O364- Maternal care for intrauterine death

Interventions

Intervention1: Tablet Mifepristone 200mg per oral: Anti-progesterone drug, synthetic steroid, used for termination of pregnancy. This will be followed by administration of Tablet Misoprostol per vagi

Eligibility

Inclusion criteria

Inclusion criteria: 1) =28 weeks 2) Primi-gravida/multi-gravida 3) Singleton pregnancy

Exclusion criteria

Exclusion criteria: 1) Previously scarred uterus 2) Re-induction 3) Multi-fetal pregnancy 4) HDP – Hypertensive disorders of pregnancy

Design outcomes

Secondary

Measure	Time frame
a. Incidence of intrapartum fever b. Need of Oxytocin for augmentation c. Number of doses of Misoprostol d. Incidence of uterine atony/ PPH/ need for blood transfusion e. Incidence of failed induction f. Incidence of uterine tachysystole Timepoint: 2 years	—

Primary

Measure	Time frame
Induction to delivery intervalTimepoint: 2 years	—

Countries

India

Contacts

Public ContactDr Bidita Biswas

Christian Medical College, Vellore

swatixrathore@gmail.com9080566712

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026